ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3025

FcγRIIIa-Psyk Signaling up-Regulates TLR3 and TLR5 in Human Naïve CD4+ T-Cells

Chen Chen1, Ye Bi2, Terry Moore3 and Anil K. Chauhan4, 1Rheumatology/Internal Medicine, Saint Louis University, St. Louis, MO, 2Internal Medicine, Saint Louis University, St. Louis, MO, 3Division of Rheumatology and Pediatric Rheumatology, Saint Louis University School of Medicine, St Louis, MO, 4Internal Medicine-Rheumatology, Saint Louis University, St Louis, MO

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: auto-immunity and interferons, Immune Dysregulation, SLE, T cells

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: T cell Biology and Targets in Autoimmune Disease Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: To delineate mechanism of FcγRIIIa-pSyk signal in TH17 and IFN-γhigh subset development. To examine whether Toll-like receptor signaling play a role in CD4+ T-cell differentiation upon FcγRIIIa ligation by immune complexes (ICs).

Methods: Purified naïve CD4+CD45RA+ T-cells were co-stimulated with plate bound ICs+C5b-9 or anti-CD28 in the presence of anti-CD3 and polarized in TH17 cytokine milieu. Flow analysis was performed for IFN-γ, IL-17A, IL-22 cytokines and pSyk. The CD4+ T-cells from SLE patients (n=40) were analyzed for pSyk and CD25, CD69 and CD98. TLR signaling genes were analyzed by RT2 Profiler QT-PCR arrays. Association of HMGB1 and MyD88 with FcγRIIIa was examined using IP and Western blotting. Cell staining was performed for co-localization of HMGB1, MyD88, TLR3, and TLR5 with labeled ICs.

Results: We show that the activated naïve CD4+ T-cells express FcγRIIIa, which upon IC ligation signals via pSyk and drive CD4+ T-cell differentiation in vitro. In SLE patients activated CD4+ T-cells that express CD25, CD69 and CD98 show pSyk. These pSyk+ cells express ICOS but not PD1.  Both MyD88 dependent and independent TLRs, 2 (5.50-fold), 3 (9.89), 5 (5.17), 8 (5.09), and 10 (5.16) were upregulated. TLR7 and 9 did not show significant increase. Adaptor and TLR interacting proteins BTK, HMGB1, HRAS, and MyD88 were upregulated.  Labeled ICs co-localize with HMGB1 and MyD88 in CD4+ T-cells. Western blots of IPs generated with anti-FcγRIIIa antibody show association of HMGB1 and MyD88 with these receptors. These results suggest a role for FcγRIIIa-pSyk signaling by upregulation of TLR pathway in defining adaptive immune responses in autoimmune pathology.

Conclusion: Recently TLR-dependent T-cell activation in autoimmunity has been documented. While TLR2 provide a co-stimulatory signal to CD4+ T-cells, TLR4 enhance activation and persistence of TH17 and TH1 cells. TLR3 contribute to the development of TH1 cells.  We observed up-regulation of TLR-signaling pathway genes in CD4+ T-cells from FcγRIIIa ligation by SLE-ICs. The pSyk+ CD4+T-cells in SLE patients produce IFN-γ and IL-17A suggesting a role of ICs in driving T-cell mediated disease pathology. A role for FcγRIIIa was further confirmed from in vitro generation of TH1 and TH17 like population. We propose that FcγRIIIa-pSyk signal drives the generation of refractory TH1 and TH17 cells that override the suppression from Tregs. Such cells are produced in response to activation from anti-CD3+anti-CD28 co-stimulation and LPS. Further MyD88 ablation impairs both TH1 and TH17 responses. Our data describe a new role for FcγRIIIa-pSyk mediated signaling in production of pro-inflammatory CD4+ T-cells that are refractory to suppression by Tregs.


Disclosure: C. Chen, None; Y. Bi, None; T. Moore, None; A. K. Chauhan, None.

To cite this abstract in AMA style:

Chen C, Bi Y, Moore T, Chauhan AK. FcγRIIIa-Psyk Signaling up-Regulates TLR3 and TLR5 in Human Naïve CD4+ T-Cells [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/fcriiia-psyk-signaling-up-regulates-tlr3-and-tlr5-in-human-nave-cd4-t-cells/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fcriiia-psyk-signaling-up-regulates-tlr3-and-tlr5-in-human-nave-cd4-t-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology